Stay updated on Trastuzumab Combo in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Trastuzumab Combo in Gastric Cancer Clinical Trial page.

Latest updates to the Trastuzumab Combo in Gastric Cancer Clinical Trial page
- Check6 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.2%
- Check13 days agoChange DetectedThe web page has been updated to include new facility names and locations, as well as additional drug information, particularly for Cisplatin and Gastrectomy. Notably, several previous entries related to drug information and locations have been removed.SummaryDifference16%
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check35 days agoChange DetectedThe page has been updated to reflect an increase in study locations from 43 to 48, with new hospitals added in Seoul, Korea, and Torino, Italy. Additionally, the revision number has been updated to v2.16.11.SummaryDifference5%
- Check50 days agoChange DetectedThe page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and it now includes information about HHS Vulnerability Disclosure.SummaryDifference0.2%
- Check57 days agoChange DetectedThe web page has been updated from version 2.16.5 to version 2.16.6.SummaryDifference0.1%
Stay in the know with updates to Trastuzumab Combo in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Trastuzumab Combo in Gastric Cancer Clinical Trial page.